Demonstrates proof of principle for pharmacological targeting aimed at controlling translation of specific mRNAs using small molecule ligands.
No takes yet. Share an insight, caveat, or question.
May inform mRNA-specific therapeutic development; leaves open human safety and efficacy.
Harvey et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: